Cargando…
Effects of the COVID‐19 pandemic on clinically diagnosed psychiatric disorders in persons with type 2 diabetes
AIMS: To examine whether the incidence rates of diagnosed depression, anxiety disorders and stress reactions, as well as prescription rates of antidepressants and anxiolytics were higher during the COVID‐19 pandemic than before in persons with type 2 diabetes in Germany. Contrary to earlier studies,...
Autores principales: | Kowall, Bernd, Kostev, Karel, Landgraf, Rüdiger, Hauner, Hans, Bierwirth, Ralf, Rathmann, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111356/ https://www.ncbi.nlm.nih.gov/pubmed/35426166 http://dx.doi.org/10.1111/dme.14852 |
Ejemplares similares
-
Routine care for people with newly diagnosed type 2 diabetes before and during the SARS-CoV-2 pandemic – results from the German Disease Analyzer database
por: Kowall, Bernd, et al.
Publicado: (2023) -
Diabetes incidence before and after COVID-19 vaccination – Results from the German Disease Analyzer database
por: Kowall, Bernd, et al.
Publicado: (2023) -
Incidence of newly diagnosed diabetes after Covid-19
por: Rathmann, Wolfgang, et al.
Publicado: (2022) -
HbA(1c) for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?
por: Kowall, Bernd, et al.
Publicado: (2013) -
Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer database
por: Rathmann, Wolfgang, et al.
Publicado: (2022)